sglt2 inhibitors vs glp-1 agonists View of Diabetes medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, and long-acting receptor complement each other to save lives by different mechanisms? The Role of SGLT 2
Description
Frit: During SPPS, this porous filter holds the resin base in place while allowing liquids (such as solvents) to drain from the peptide reactor

These renal protective mechanisms establish GLP-1 receptor agonists as preferred treatments for diabetes care in individuals with varying degrees of kidney damage, with evidence endorsing their use down to an eGFR of 15 mL/min/1.73m2 for specific medications

This effect can be specifically blocked by the GLP-1R antagonist exendin (939) amide

Hou J, Xiong W, Cao L, Wen X, Li A (2015) Spironolactone add-on for preventing or slowing the progression of diabetic nephropathy: a meta-analysis
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
Tirzepatide was undetectable (below 4 micrograms per liter) in 164 of 171 samples

Finally, elevated cAMP concentrations, in combination with Ex-4, activate the p38 signaling pathway in breast cancer cells, resulting in decreased cell growth and increased apoptosis [58]
